Diplomat Pharmacy, Inc. EBITDA Margin 2014-2019 | DPLO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Diplomat Pharmacy, Inc. (DPLO) over the last 10 years. The current EBITDA margin for Diplomat Pharmacy, Inc. as of September 30, 2019 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2019-09-30 | $5.21B | $-0.06B | -1.09% |
| 2019-06-30 | $5.28B | $0.01B | 0.11% |
| 2019-03-31 | $5.41B | $0.05B | 0.83% |
| 2018-12-31 | $5.49B | $0.06B | 1.09% |
| 2018-09-30 | $5.29B | $0.13B | 2.36% |
| 2018-06-30 | $5.04B | $0.11B | 2.16% |
| 2018-03-31 | $4.75B | $0.10B | 2.04% |
| 2017-12-31 | $4.49B | $0.09B | 1.94% |
| 2017-09-30 | $4.48B | $0.09B | 1.92% |
| 2017-06-30 | $4.53B | $0.08B | 1.81% |
| 2017-03-31 | $4.49B | $0.09B | 1.91% |
| 2016-12-31 | $4.41B | $0.10B | 2.20% |
| 2016-09-30 | $4.25B | $0.09B | 2.19% |
| 2016-06-30 | $4.02B | $0.12B | 2.86% |
| 2016-03-31 | $3.74B | $0.11B | 2.81% |
| 2015-12-31 | $3.37B | $0.08B | 2.32% |
| 2015-09-30 | $2.99B | $0.06B | 2.11% |
| 2015-06-30 | $2.64B | $0.04B | 1.33% |
| 2015-03-31 | $2.38B | $0.02B | 0.93% |
| 2014-12-31 | $2.22B | $0.02B | 0.95% |
| 2014-09-30 | $2.00B | $0.02B | 1.15% |
